Glenmark Pharma: HSBC sees 21% upside after ‘first-to-market’ US FDA win
- Posted on March 18, 2026
- By Financial Express
- 3 Views
Glenmark Pharma: HSBC sees 21% upside after ‘first-to-market’ US FDA win
A key US drug approval is putting this pharma stock back on the radar, with a global brokerage pointing to fresh triggers beyond just one product.
